In addition, the prognosis of Philadelphia chromosome in (Ph)/BCR/ABL-positive ALL patients has dramatically improved upon the introduction of BCR–ABL tyrosine kinase inhibitors [18]. The gene discussed is ABL1; the disease is acute lymphoblastic leukemia.